MATN2 and metastatic neoplasm: Notably, CCT365623 and BAPN elicit a significant reduction in MATN2 protein levels in both the primary and metastatic lung tumours and this is accompanied by the loss of EGFR from the plasma membranes of the cells in both the primary and metastatic tumours (Fig. 7g–l).